Do older patients truly benefit from advances in myeloma care?

por Gatt, Moshe E., Lebel, Eyal
Publicado 2022

The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression

por Gilad, Nechama, Zukerman, Hila, Pick, Marjorie, Gatt, Moshe E.
Publicado 2019

Suppression of multiple myeloma by mitochondrial targeting

por Aisen, Yana, Gatt, Moshe E., Hertz, Rachel, Smeir, Elia, Bar-Tana, Jacob
Publicado 2021

Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma

por Lebel, Eyal, Nachmias, Boaz, Pick, Marjorie, Gross Even-Zohar, Noa, Gatt, Moshe E.
Publicado 2022

Prolonged Fever, Hepatosplenomegaly, and Pancytopenia in a 46-Year-Old Woman

por Levy, Liran, Nasereddin, Abedelmajeed, Rav-Acha, Moshe, Kedmi, Meirav, Rund, Deborah, Gatt, Moshe E.
Publicado 2009

Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospect...

por Morgenstern, Yael, Aumann, Shlomzion, Goldschmidt, Neta, Gatt, Moshe E., Nachmias, Boaz, Horowitz, Netanel A.
Publicado 2021

CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival

por Gross Even-Zohar, Noa, Pick, Marjorie, Hofstetter, Liron, Shaulov, Adir, Nachmias, Boaz, Lebel, Eyal, Gatt, Moshe E.
Publicado 2022

Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest

por Nachmias, Boaz, Krichevsky, Svetlana, Gatt, Moshe E., Gross Even-Zohar, Noa, Shaulov, Adir, Haran, Arnon, Aumann, Shlomzion, Vainstein, Vladimir
Publicado 2023

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma

por Harush, Ortal, Asherie, Nathalie, Kfir-Erenfeld, Shlomit, Adler, Galit, Barliya, Tilda, Assayag, Miri, Gatt, Moshe E., Stepensky, Polina, Cohen, Cyrille J.
Publicado 2022

Monitoring Minimal Residual Disease in RUNX1-Mutated Acute Myeloid Leukemia

por Nachmias, Boaz, Krichevsky, Svetlana, Filon, Dvora, Even-Or, Ehud, Gatt, Moshe E., Saban, Revital, Avni, Batia, Grisariu, Sigal, Aumann, Shlomzion, Vainstein, Vladimir
Publicado 2022

Amyloidogenic light chains impair plasma cell survival

por Pick, Marjorie, Lebel, Eyal, Elgavish, Sharona, Benyamini, Hadar, Nevo, Yuval, Hertz, Rachel, Bar-Tana, Jacob, Rognoni, Paola, Merlini, Giampaolo, Gatt, Moshe E.
Publicado 2023

Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study

por Lebel, Eyal, Kastritis, Efstathios, Palladini, Giovanni, Milani, Paolo, Theodorakakou, Foteini, Aumann, Shlomzion, Lavi, Noa, Shargian, Liat, Magen, Hila, Cohen, Yael, Gatt, Moshe E., Vaxman, Iuliana
Publicado 2023

Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial

por Asherie, Nathalie, Kfir-Erenfeld, Shlomit, Avni, Batia, Assayag, Miri, Dubnikov, Tatyana, Zalcman, Nomi, Lebel, Eyal, Zimran, Eran, Shaulov, Adir, Pick, Marjorie, Cohen, Yael, Avivi, Irit, Cohen, Cyrille, Gatt, Moshe E., Grisariu, Sigal, Stepensky, Polina
Publicado 2022

Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?

por Vainstein, Vladimir, Avni, Batia, Grisariu, Sigal, Kfir-Erenfeld, Shlomit, Asherie, Nathalie, Nachmias, Boaz, Auman, Shlomtzion, Saban, Revital, Zimran, Eran, Assayag, Miri, Filanovsky, Kalman, Horowitz, Netanel A., Lebel, Eyal, Shaulov, Adir, Gur, Michal, Rosenbluh, Chaggai, Krichevsky, Svetlana, Stepensky, Polina, Gatt, Moshe E.
Publicado 2023

An mTORC1 to HRI signaling axis promotes cytotoxicity of proteasome inhibitors in multiple myeloma

por Darawshi, Odai, Muz, Barbara, Naamat, Shiri Gershon, Praveen, Bellam, Mahameed, Mohamed, Goldberg, Karin, Dipta, Priya, Shmuel, Miriam, Forno, Francesca, Boukeileh, Shatha, Pahima, Hadas, Hermann, Julia, Raab, Marc S., Poos, Alexandra M., Weinhold, Niels, Rosenbluh, Chaggai, Gatt, Moshe E., Palm, Wilhelm, Azab, Abdel Kareem, Tirosh, Boaz
Publicado 2022

Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA

por Hiayev, Stephany, Shacham-Shmueli, Einat, Berkovitch, Matitiahu, Weiss, Ilana, Ashkenazi, Shai, Vexberg, Michal Hirsch, Hershkowitz, Rami, Gorelik, Einat, Mayan, Haim, Steinmetz, Yehudit, Yanai, Noa Berar, Schlissel, Orly, Azem, Muhammad, Gutgold, Neriya, Shulman, Katerina, Divinsky, Milly, Yarom, Nirit, Vishkautzan, Alla, Ganzel, Chezi, Gatt, Moshe E, Arcavi, Lidia, Marom, Eli, Uziely, Biatrice, Zevin, Shoshana, Meirow, Hadar, Luxenburg, Osnat, Ainbinder, Denize
Publicado 2023

Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated wit...

por Richardson, Paul G., Nagler, Arnon, Ben‐Yehuda, Dina, Badros, Ashraf, Hari, Parameswaran N., Hajek, Roman, Spicka, Ivan, Kaya, Hakan, LeBlanc, Richard, Yoon, Sung‐Soo, Kim, Kihyun, Martinez‐Lopez, Joaquin, Mittelman, Moshe, Shpilberg, Ofer, Blake, Paul, Hideshima, Teru, Colson, Kathleen, Laubach, Jacob P., Ghobrial, Irene M., Leiba, Merav, Gatt, Moshe E., Sportelli, Peter, Chen, Michael, Anderson, Kenneth C.
Publicado 2020